Skip to main content
Norman Foster, MD, Neurology, Salt Lake City, UT

NormanL.FosterMD

Neurology • Salt Lake City, UT

Professor in the Department of Neurology, Chief of the Division of Cognitive Neurology, Director of the Center for Alzheimer's Care, Imaging and Research (CACIR), and Senior Investigator for the Brain Institute at the University of Utah

Join to view full profile

Dr. Foster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Foster's full profile

Already have an account?

  • Office

    50 N Medical Dr
    Salt Lake City, UT 84132
    Phone+1 801-585-6387

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthResidency, Neurology, 1981 - 1984
  • University of Utah Health
    University of Utah HealthResidency, Neurology, 1978 - 1981
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1977 - 1978
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1977

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 1979 - 2024
  • MI State Medical License
    MI State Medical License 1984 - 2009
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Battle over Medicare/Medicaid’s Failure to Cover Approved Alzheimer’s Drugs
    Battle over Medicare/Medicaid’s Failure to Cover Approved Alzheimer’s DrugsMay 19th, 2023
  • Eisai and Biogen’s Lecanemab Moves Closer to Traditional FDA Approval
    Eisai and Biogen’s Lecanemab Moves Closer to Traditional FDA ApprovalApril 4th, 2023
  • ‘Nothing-Can-Be-Done’ View of Alzheimer’s Disease Untrue
    ‘Nothing-Can-Be-Done’ View of Alzheimer’s Disease UntrueJanuary 24th, 2023
  • Join now to see all

Grant Support

  • Predicting Individual Progression In Alzheimer'S DiseaseNational Institute On Aging2005–2009
  • Core--Clinical CoreNational Institute On Aging2005–2009
  • Michigan Alzheimer?S Disease Research Center D(Longitudinal Cohort) D Minority SNational Center For Research Resources2006
  • Pilot Collaborative PET Imaging TrialNational Institute On Aging2005
  • Michigan Alzheimer?S Disease Research Center D(Longitudinal Cohort) D MinorityNational Center For Research Resources2005
  • Michigan Alzheimer'S Disease Research Center (Longitudinal Cohort)National Center For Research Resources2004
  • Pilot Collaborative PET Imaging TrialNational Institute On Aging2003–2004
  • Apolipoprotein E &Presenilin-1 Testing In Alzheimer'S DiseaseNational Center For Research Resources2000–2002
  • Core--ClinicalNational Institute On Aging1996–2002
  • Neuropharmacologic Challenges In DementiaNational Center For Research Resources1996–2000
  • Neuropharmacologic Challenges In DementiaNational Institute On Aging1996–1998
  • Conference On Chromosome 17--Linked DementiasNational Institute On Aging1996
  • Neuropharmacologic Challenges In DementiaNational Institute Of Mental Health1990–1992
  • PET Investigations Of Alheimers DiseaseNational Institute Of Neurological Disorders And Stroke1985–1989

Dr. Norman Foster, Dr. Norman Foster, MD, Dr. N Foster, Dr. Norman L. Foster